Compugen Stems Q2 Losses While Hunting for Products and Partners | GenomeWeb
NEW YORK (GenomeWeb News) — Compugen yesterday reported it earned no revenues for the second quarter of 2007, while R&D spending was down 15 percent and net loss was cut 11 percent.
 
The company reported $5,000 in revenue for the second quarter of 2006.           .
 
Compugen said R&D spending in the quarter dipped to $2.3 million from $2.7 million year over year.
 
Net loss was lowered slightly to $3.2 million from $3.6 million over the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.